Premsai Chilakuluri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Premsai Chilakuluri has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Aruni Ghose
Cardio-Oncology Service, University College London Hospitals NHS Foundation Trust, London NW1 2PG, UK
1 shared publication - David Bamidele Olawade
University of East London
1 shared publication - Elisabet Sanchez
Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK
1 shared publication - Jennifer Teke
Department of Research and Innovation, Medway NHS Foundation Trust, Gillingham ME7 5NY, the United Kingdom of Great Britain and Northern Ireland; Faculty of Medicine, Health and Social Care, Canterbury Christ Church University, the United Kingdom of Great Britain and Northern Ireland
1 shared publication - Mahmudul Rahat Hasan
Department of Acute Medicine, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK
1 shared publication - Michel-Elie Bachour
Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK
1 shared publication
Latest Publications
- Open Access
- 10 March 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (3) , 401
Spinal MRI in Patients with Suspected Metastatic Spinal Cord Compression: A Quality Improvement Audit in a District General Hospital in Kent, UK
Metastatic spinal cord compression (MSCC) is a common complication in cancer patients, occurring in 3–5% of diagnosed cases annually, and serves as the initial manifestation of malignancy in 20% of patients. Timely diagnosis and management are critical due to the risk of irreversible neurological damage and the significant impact on both quality and quantity of life. The National Institute for Health and Care Excellence (NICE) recommends that patients presenting with back pain accompanied by neurological signs and/or symptoms undergo whole-spine magnetic resonance imaging (MRI) within 24 h. This retrospective study at Medway Maritime Hospital in England aimed to assess adherence to these guidelines by reviewing the time from presentation to MRI for patients exhibiting symptoms and/or signs of MSCC. Data for 69 patients were collected over one year using electronic patient records and the acute oncology service database. Analysis revealed that MRI was conducted within 24 h in only 43 out of 69 cases (62%), and 16 out of 25 delayed cases (i.e., MRI done beyond the recommended 24 h window) experienced delays of more than 48 h. To improve guideline adherence, interventions such as informational flyers and regular MSCC training sessions, including trainee teaching and presentations during grand rounds, were implemented. A follow-up re-audit involving 113 patients over one year demonstrated improved adherence to the 24 h MRI guideline, with 81 out of 113 cases (71%) meeting the target. The second cycle also documented reasons for delays, identifying patient compliance and pain control as primary factors. Additionally, the timing of steroid administration following suspicion of MSCC was recorded. Future studies should re-assess adherence, focus on better documentation of delay causes, enhance pain management before MRI scans, and ensure prompt steroid administration.
- 10 March 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (3) , 401
Open AccessSpinal MRI in Patients with Suspected Metastatic Spinal Cord Compression: A Quality Improvement Audit in a District General Hospital in Kent, UK
Metastatic spinal cord compression (MSCC) is a common complication in cancer patients, occurring in 3–5% of diagnosed cases annually, and serves as the initial manifestation of malignancy in 20% of patients. Timely diagnosis and management are critical due to the risk of irreversible neurological damage and the significant impact on both quality and quantity of life. The National Institute for Health and Care Excellence (NICE) recommends that patients presenting with back pain accompanied by neurological signs and/or symptoms undergo whole-spine magnetic resonance imaging (MRI) within 24 h. This retrospective study at Medway Maritime Hospital in England aimed to assess adherence to these guidelines by reviewing the time from presentation to MRI for patients exhibiting symptoms and/or signs of MSCC. Data for 69 patients were collected over one year using electronic patient records and the acute oncology service database. Analysis revealed that MRI was conducted within 24 h in only 43 out of 69 cases (62%), and 16 out of 25 delayed cases (i.e., MRI done beyond the recommended 24 h window) experienced delays of more than 48 h. To improve guideline adherence, interventions such as informational flyers and regular MSCC training sessions, including trainee teaching and presentations during grand rounds, were implemented. A follow-up re-audit involving 113 patients over one year demonstrated improved adherence to the 24 h MRI guideline, with 81 out of 113 cases (71%) meeting the target. The second cycle also documented reasons for delays, identifying patient compliance and pain control as primary factors. Additionally, the timing of steroid administration following suspicion of MSCC was recorded. Future studies should re-assess adherence, focus on better documentation of delay causes, enhance pain management before MRI scans, and ensure prompt steroid administration.